Blistra

Blistra

nicardipine

Manufacturer:

Pharos
Concise Prescribing Info
Contents
Nicardipine HCl
Indications/Uses
Emergency treatment of acute HTN during surgery. Hypertensive emergencies.
Dosage/Direction for Use
Emergency treatment of acute HTN during surgery 0.01-0.02% IV drip infusion (equiv 0.1-0.2 mg/mL) at a starting rate of 2-10 mcg /kg/min until the desired BP value is reached. Rapid BP reduction 10-30 mcg/kg/min IV inj. Hypertensive emergency 0.01-0.02% IV drip infusion (equiv 0.1-0.2 mg/mL) at a rate of 0.5 mcg/kg/min until the desired BP value is reached.
Contraindications
Suspected incomplete hemostasis following intracranial hemorrhage; elevated intracranial pressure at the acute stage of cerebral stroke.
Special Precautions
Aortic stenosis. Hepatic or renal dysfunction.
Adverse Reactions
Paralytic ileus, hypoxemia, anginal pain, thrombocytopenia.
Drug Interactions
Saquinavir, ritonavir, β-blockers, fentanyl, cimetidine, digoxin, phenytoin, rifampicin, dantrolene Na, tandospirone citrate, nitroglycerin, pancuronium Br, vecuronium Br.
MIMS Class
Calcium Antagonists
ATC Classification
C08CA04 - nicardipine ; Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
Presentation/Packing
Form
Blistra inj 10 mg/10 mL
Packing/Price
(amp) 10 × 1's (Rp2,047,500/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in